Showing results (71-80 of 153) with videos related to
Sort By:
Pageof 16
Anticancer Research|February 4, 2019
Radiosensitization of Glioblastoma Cells by a Novel DNA Methyltransferase-inhibiting Phthalimido-Alkanamide DerivativeChan Woo Wee, Jin Ho Kim, Hak Jae Kim, et al.Biomaterials|May 15, 2012
Doxorubicin-loaded highly porous large PLGA microparticles as a sustained- release inhalation system for the treatment of metastatic lung cancerInsoo Kim, Hyeong Jun Byeon, Tae Hyung Kim, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|March 29, 2023
Novel LC-MS/MS analysis of the GLP-1 analog semaglutide with its application to pharmacokinetics and brain distribution studies in ratsTae Suk Lee, Eun Ji Park, Minkyu Choi, et al.Bioconjugate Chemistry|November 12, 2014
Human serum albumin-TRAIL conjugate for the treatment of rheumatoid arthritisHyeong Jun Byeon, Sun Young Min, Insoo Kim, et al.Anticancer Research|January 31, 2021
Newly Synthesized DNA Methyltransferase Inhibitors as Radiosensitizers for Human Lung Cancer and Glioblastoma CellsChan Woo Wee, Jin Ho Kim, Hak Jae Kim, et al.Archives of Pharmacal Research|May 15, 2014
Preparation and evaluation of 17-allyamino-17-demethoxygeldanamycin (17-AAG)-loaded poly(lactic acid-co-glycolic acid) nanoparticlesRoshan Pradhan, Bijay Kumar Poudel, Ju Yeon Choi, et al.Journal of Materials Chemistry. B|April 9, 2020
Systemic delivery of axitinib with nanohybrid liposomal nanoparticles inhibits hypoxic tumor growthJu Yeon Choi, Thiruganesh Ramasamy, Tuan Hiep Tran, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 31, 2016
Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumorsHyeong Jun Byeon, Le Quang Thao, Seunghyun Lee, et al.Pharmaceutical Research|December 5, 2014
Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo CharacterizationThiruganesh Ramasamy, Ju Yeon Choi, Hyuk Jun Cho, et al.Antimicrobial Agents and Chemotherapy|January 18, 2018
Combating Carbapenem-Resistant Acinetobacter baumannii by an Optimized Imipenem-plus-Tobramycin Dosage Regimen: Prospective Validation via Hollow-Fiber Infection and Mathematical ModelingCornelia B Landersdorfer, Rajbharan Yadav, Kate E Rogers, et al.Pageof 16